Aim: We report the first patient roadmap in severe chronic low back pain (cLBP) in Europe, assessing the views of cLBP patients and general practitioners (GPs) who treat cLBP with regard to current cLBP management. Methodology: Patient journey mapping was conducted in four European countries to assess the views of cLBP patients (n = 20) and GPs (n = 40). Results: Four broad phases of cLBP, subdivided into eight individual steps, were identified as part of the patient journey, showing a disconnect between patients’ and physicians’ treatment goals, and expectations regarding pain relief levels for some patients. Conclusion: Improved communication, with greater involvement of patients in multimodal management decisions, might benefit the GP–patient relationship and overall outcomes for cLBP patients.

Keywords:

Papers of special note have been highlighted as: • of interest

References

1. GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053), 1603–1658 (2016).
MedlineGoogle Scholar
2. GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159), 1859–1922 (2018).
MedlineGoogle Scholar
3. Shmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back pain in US adults: data from the 2009–2010 National Health and Nutrition Examination Survey. Arthritis Care Res. (Hoboken) 68(11), 1688–1694 (2016).
MedlineGoogle Scholar
4. Meucci RD, Fassa AG, Faria NM. Prevalence of chronic low back pain: systematic review. Rev. Saude Publica. 49, 1 (2015).
MedlineGoogle Scholar
5. Hägg O, Burckhardt C, Fritzell P et al. Quality of life in chronic low back pain: a comparison with fibromyalgia and the general population. J. Musculoskelet. Pain 11(1), 31–38 (2003).
Google Scholar
6. Husky MM, Ferdous Farin F, Compagnone P et al. Chronic back pain and its association with quality of life in a large French population survey. Health Qual. Life Outcomes 16(1), 195 (2018).
MedlineGoogle Scholar
7. Wettstein M, Eich W, Bieber C et al. Pain intensity, disability, and quality of life in patients with chronic low back pain: does age matter? Pain Med. 20(3), 464–475 (2019).
MedlineGoogle Scholar
8. Raczkiewicz D, Owoc A, Sarecka-Hujar B et al. Impact of spinal pain on daily living activities in postmenopausal women working in agriculture. Ann. Agric. Environ. Med. 24(1), 134–140 (2017).
MedlineGoogle Scholar
9. Australian Institute of Health and Welfare. Impacts of chronic back problems. Bulletin 137. Cat. No. 204. Canberra: AIHW, 2016. www.aihw.gov.au/reports/chronic-musculoskeletal-conditions/impacts-of-chronic-back-problems/data
Google Scholar
10. Hoy D, Brooks P, Blyth F et al. The Epidemiology of low back pain. Best Pract. Res. Clin. Rheumatol. 24(6), 769–781 (2010).
Medline CASGoogle Scholar
11. Dutmer AL, Schiphorst Preuper HR, Soer R et al. Personal and societal impact of low back pain: the Groningen Spine Cohort. Spine (Phila Pa 1976) 44(24), E1443–E1451 (2019).
MedlineGoogle Scholar
12. Mutubuki EN, Luitjens MA, Maas ET et al. Predictive factors of high societal costs among chronic low back pain patients. Eur. J. Pain 24(2), 325–337 (2020). • Recent study highlighting the significant personal and societal burden of low back pain.
MedlineGoogle Scholar
13. Katz JN. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J. Bone Joint Surg. Am. 88(Suppl. 2), 21–24 (2006). • A US study highlighting that the cost of low back pain exceeds $100 billion per year.
MedlineGoogle Scholar
14. Olafsson G, Jonsson E, Fritzell P et al. Cost of low back pain: results from a national register mapping in Sweden. Eur. Spine J. 27(11), 2875–2881 (2018).
MedlineGoogle Scholar
15. Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain 84(1), 95–103 (2000).
Medline CASGoogle Scholar
16. Itoh H, Kitamura F, Yokoyama K. Estimates of annual medical costs of work-related low back pain in Japan. Ind. Health 51(5), 524–529 (2013).
MedlineGoogle Scholar
17. Coulter A, Fitzpatrick R, Cornwell J. The point of care: measures of patients’ experience in hospital: purpose, methods and uses. The King’s Fund. 2009; 1–32. www.kingsfund.org.uk/sites/default/files/Point-of-Care-Measures-of-patients-experience-in-hospital-Kings-Fund-July-2009_0.pdf
Google Scholar
18. Mould G, Bowers J, Ghattas M. The evolution of the pathway and its role in improving patient care. Qual. Saf. Health Care 19(5), e14 (2010).
Medline CASGoogle Scholar
19. Grocott MP. Pathway redesign: putting patients ahead of professionals. Clin. Med. (Lond.) 19(6), 468–472 (2019).
MedlineGoogle Scholar
20. Ben-Tovim DI, Dougherty ML, O’Connell TJ et al. Patient journeys: the process of clinical redesign. Med. J. Aust. 188(S6), S14–S17 (2008).
MedlineGoogle Scholar
21. The Health Foundation. No. 19. Improving patient flow across organisations and pathways. (2013). www.health.org.uk/publications/improving-patient-flow-across-organisations-and-pathways
Google Scholar
22. petesaunders.com. The benefits of patient experience and journey mapping in health care. (2018). www.petesaunders.com/the-benefits-of-patient-experience-and-journey-mapping-in-health-care/
Google Scholar
23. Doyle C, Lennox L, Bell D. A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open 3(1), 1–18 (2013).
Google Scholar
24. Albornoz-Cabello M, Maya-Martín J, Domínguez-Maldonado G et al. Effect of interferential current therapy on pain perception and disability level in subjects with chronic low back pain: a randomized controlled trial. Clin. Rehabil. 31(2), 242–249 (2017).
MedlineGoogle Scholar
25. Morlion B, Coluzzi F, Aldington D et al. Pain chronification: what should a non-pain medicine specialist know? Curr. Med. Res. Opin. 34(7), 1169–1178 (2018).
MedlineGoogle Scholar
26. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm. Rep. 65(1), 1–49 (2016).
MedlineGoogle Scholar
27. Faculty of Pain Medicine of the Royal College of Anaesthetists. Opioids aware: a resource for patients and healthcare professionals to support prescribing of opioid medicines for pain. https://www.fpm.ac.uk/opioids-aware
Google Scholar
28. Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci. Pract. Perspect. 1, 13–20 (2002).
MedlineGoogle Scholar
29. Manchikanti L, Kaye AM, Knezevic NN et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician 20(2S), S3–S92 (2017).
MedlineGoogle Scholar
30. Corp N, Mansell G, Stynes S et al. Evidence-based treatment recommendations for neck and low back pain across Europe: a systematic review of guidelines. Eur. J. Pain 25(2), 275–295 (2021).
MedlineGoogle Scholar
31. Tucker HR, Scaff K, McCloud T et al. Harms and benefits of opioids for management of non-surgical acute and chronic low back pain: a systematic review. Br. J. Sports Med. 54(11), 664 (2020).
MedlineGoogle Scholar
32. Häuser W, Morlion B, Vowles KE et al. European* clinical practice recommendations on opioids for chronic noncancer pain - Part 1: role of opioids in the management of chronic noncancer pain. Eur. J. Pain doi:10.1002/ejp.1736 (2021). (Epub ahead of print).
Google Scholar
33. Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet 389(10070), 736–747 (2017).
MedlineGoogle Scholar
34. Vasileiou K, Barnett J, Thorpe S et al. Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period. BMC Med. Res. Methodol. 18(1), 148 (2018).
MedlineGoogle Scholar

Vol. 11, No. 5

Supplemental Materials

Metrics

Downloaded 157 times

History

Received 5 February 2021

Accepted 30 March 2021

Published online 13 April 2021

Published in print September 2021

Information

Keywords

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at: www.futuremedicine.com/doi/suppl/10.2217/pmt-2021-0009

Author contributions

All the authors critically reviewed the draft manuscript and approved the final version of the manuscript for publication.

Financial & competing interests disclosure

This study was sponsored by Grünenthal GmbH, Aachen, Germany. B Morlion received honoraria for speaker’s activities for Medscape and Krka and consultancy activities for Reckitt Benckiser, Grünenthal, and Pfizer Belgium. D Aldington received honoraria for participation in Advisory Boards and the Change Pain project both with Grünenthal. G Finco and M Überall have received funding for a variety of projects from Grünenthal not related to this publication. At the time of the study and during preparation of the manuscript, R Karra was employed by Grünenthal GmbH.

Medical writing support was provided by Content Ed Net, with funding from Grünenthal GmbH, Aachen, Germany.

PDF download